Arrowstreet Capital
ABMD

Arrowstreet Capital’s Abiomed Inc ABMD Stock Holding History

Arrowstreet Capital’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-123,019
Closed -$30.2M – 1524
2022
Q3 		$30.2M Buy
123,019
+18,027
+17% +$4.87M 0.04% 304
2022
Q2 		$26M Buy
104,992
+76,712
+271% +$20.7M 0.04% 331
2022
Q1 		$9.37M Sell
28,280
-38,363
-58% -$11.8M 0.01% 525
2021
Q4 		$23.9M Sell
66,643
-13,231
-17% -$4.47M 0.03% 438
2021
Q3 		$26M Buy
79,874
+33,581
+73% +$11.4M 0.03% 456
2021
Q2 		$14.4M Buy
+46,293
New +$14.2M 0.02% 717
2019
Q2 		– Sell
-15,118
Closed -$4.32M – 1806
2019
Q1 		$4.32M Sell
15,118
-26,300
-63% -$8.74M 0.01% 844
2018
Q4 		$13.5M Buy
41,418
+19,500
+89% +$6.77M 0.04% 372
2018
Q3 		$9.86M Buy
+21,918
New +$8.64M 0.02% 415
2018
Q2 		– Sell
-41,100
Closed -$12M – 1358
2018
Q1 		$12M Buy
41,100
+23,544
+134% +$5.97M 0.03% 408
2017
Q4 		$3.29M Buy
+17,556
New +$3.28M 0.01% 701
2017
Q3 		– Sell
-26,500
Closed -$3.8M – 1287
2017
Q2 		$3.8M Sell
26,500
-122,514
-82% -$16.5M 0.01% 524
2017
Q1 		$18.7M Buy
+149,014
New +$17.3M 0.07% 280
2016
Q4 		– Sell
-548,951
Closed -$70.6M – 2662
2016
Q3 		$70.6M Buy
548,951
+299,201
+120% +$35.8M 0.23% 103
2016
Q2 		$27.3M Buy
+249,750
New +$24.8M 0.09% 223
2016
Q1 		– Sell
-13,710
Closed -$1.24M – 1592
2015
Q4 		$1.24M Sell
13,710
-81,690
-86% -$6.93M 0.01% 929
2015
Q3 		$8.85M Sell
95,400
-39,600
-29% -$3.49M 0.04% 375
2015
Q2 		$8.87M Buy
+135,000
New +$8.97M 0.05% 294
2015
Q1 		– Sell
-17,074
Closed -$650K – 1275
2014
Q4 		$650K Buy
+17,074
New +$539K ﹤0.01% 990

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arrowstreet Capital's ABMD Position: Q4 2022 in Review

Arrowstreet Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 123,019 shares — an estimated $30.2M sold.

Arrowstreet Capital first reported a position in ABMD in Q4 2014 and held it in 19 quarters. The position peaked at $70.6M in Q3 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Arrowstreet Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 123,019 Abiomed Inc shares in Q4 2022, an estimated $30.2M.
  • Arrowstreet Capital first reported a position in Abiomed Inc in Q4 2014 and held it in 19 quarters.
  • Arrowstreet Capital's Abiomed Inc position peaked at $70.6M in Q3 2016.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.